Nanhua Bio Medicine Co Ltd (000504) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanhua Bio Medicine Co Ltd (000504) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.42 Million ≈ $3.28 Million USD) by net assets (CN¥362.66 Million ≈ $53.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Nanhua Bio Medicine Co Ltd for the company's overall valuation and market capitalisation.
Nanhua Bio Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Nanhua Bio Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nanhua Bio Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanhua Bio Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore 000504 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EQV Ventures Acquisition Corp. II
NYSE:EVAC
|
0.007x |
|
Tilray Inc
TO:TLRY
|
-0.014x |
|
Zhejiang Sunrise Garment Group Co Ltd
SHG:605138
|
N/A |
|
Longjian Road & Bridge Co Ltd
SHG:600853
|
0.111x |
|
Metrogas SA
BA:METR
|
0.029x |
|
Zhejiang Talent Television&Film Co Ltd
SHE:300426
|
-0.598x |
|
Beijing Yuanlong Yato Culture Dissemination Co Ltd
SHE:002878
|
-0.096x |
|
Beijing SinoHytec Co. Ltd. A
SHG:688339
|
N/A |
Annual Cash Flow Conversion Efficiency for Nanhua Bio Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Nanhua Bio Medicine Co Ltd from 1998 to 2025. View Nanhua Bio Medicine Co Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥357.51 Million ≈ $52.31 Million |
CN¥-115.74 Million ≈ $-16.94 Million |
-0.324x | -2004.44% |
| 2024-12-31 | CN¥282.00 Million ≈ $41.27 Million |
CN¥4.79 Million ≈ $701.45K |
0.017x | -85.72% |
| 2023-12-31 | CN¥304.67 Million ≈ $44.58 Million |
CN¥36.28 Million ≈ $5.31 Million |
0.119x | -94.28% |
| 2022-12-31 | CN¥79.88 Million ≈ $11.69 Million |
CN¥166.38 Million ≈ $24.35 Million |
2.083x | +114.54% |
| 2021-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥107.10 Million ≈ $15.67 Million |
0.971x | +163.00% |
| 2020-12-31 | CN¥134.48 Million ≈ $19.68 Million |
CN¥-207.22 Million ≈ $-30.32 Million |
-1.541x | -1314.43% |
| 2019-12-31 | CN¥114.46 Million ≈ $16.75 Million |
CN¥14.52 Million ≈ $2.13 Million |
0.127x | +190.02% |
| 2018-12-31 | CN¥107.75 Million ≈ $15.77 Million |
CN¥-15.19 Million ≈ $-2.22 Million |
-0.141x | +61.81% |
| 2017-12-31 | CN¥128.43 Million ≈ $18.79 Million |
CN¥-47.40 Million ≈ $-6.94 Million |
-0.369x | -101.57% |
| 2016-12-31 | CN¥79.76 Million ≈ $11.67 Million |
CN¥-14.60 Million ≈ $-2.14 Million |
-0.183x | -115.47% |
| 2015-12-31 | CN¥-14.51 Million ≈ $-2.12 Million |
CN¥-17.17 Million ≈ $-2.51 Million |
1.184x | +125.51% |
| 2014-12-31 | CN¥7.03 Million ≈ $1.03 Million |
CN¥-32.60 Million ≈ $-4.77 Million |
-4.639x | -41.07% |
| 2013-12-31 | CN¥3.57 Million ≈ $522.49K |
CN¥-11.74 Million ≈ $-1.72 Million |
-3.289x | -1699.99% |
| 2012-12-31 | CN¥-20.80 Million ≈ $-3.04 Million |
CN¥-4.28 Million ≈ $-625.68K |
0.206x | +958.05% |
| 2011-12-31 | CN¥130.38 Million ≈ $19.08 Million |
CN¥-3.12 Million ≈ $-457.01K |
-0.024x | +93.96% |
| 2010-12-31 | CN¥161.13 Million ≈ $23.58 Million |
CN¥-63.95 Million ≈ $-9.36 Million |
-0.397x | -195.00% |
| 2009-12-31 | CN¥144.30 Million ≈ $21.12 Million |
CN¥60.28 Million ≈ $8.82 Million |
0.418x | +725.04% |
| 2008-12-31 | CN¥278.16 Million ≈ $40.70 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.067x | -425.61% |
| 2007-12-31 | CN¥449.00 Million ≈ $65.70 Million |
CN¥9.22 Million ≈ $1.35 Million |
0.021x | +1169.29% |
| 2006-12-31 | CN¥443.78 Million ≈ $64.94 Million |
CN¥717.62K ≈ $105.01K |
0.002x | -93.67% |
| 2005-12-31 | CN¥445.86 Million ≈ $65.24 Million |
CN¥11.40 Million ≈ $1.67 Million |
0.026x | -14.73% |
| 2004-12-31 | CN¥443.86 Million ≈ $64.95 Million |
CN¥13.31 Million ≈ $1.95 Million |
0.030x | -77.23% |
| 2003-12-31 | CN¥423.50 Million ≈ $61.97 Million |
CN¥55.75 Million ≈ $8.16 Million |
0.132x | +221.97% |
| 2002-12-31 | CN¥387.30 Million ≈ $56.67 Million |
CN¥15.83 Million ≈ $2.32 Million |
0.041x | -61.50% |
| 2001-12-31 | CN¥322.29 Million ≈ $47.16 Million |
CN¥34.22 Million ≈ $5.01 Million |
0.106x | +1318.35% |
| 2000-12-31 | CN¥385.75 Million ≈ $56.45 Million |
CN¥-3.36 Million ≈ $-491.98K |
-0.009x | +21.76% |
| 1999-12-31 | CN¥173.52 Million ≈ $25.39 Million |
CN¥-1.93 Million ≈ $-282.86K |
-0.011x | -218.50% |
| 1998-12-31 | CN¥352.69 Million ≈ $51.61 Million |
CN¥3.32 Million ≈ $485.17K |
0.009x | -- |
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment provides stem cell and immune cell testing, storage, and technical services; as well as sales of biopharmaceutical products, such as beauty products, health supplements, and air purifiers. The Energy Saving and… Read more